US5789184A
(en)
*
|
1993-03-31 |
1998-08-04 |
Cadus Pharmaceutical Corporation |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US7416881B1
(en)
*
|
1993-03-31 |
2008-08-26 |
Cadus Technologies, Inc. |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US6255059B1
(en)
|
1993-03-31 |
2001-07-03 |
Cadus Pharmaceutical Corporation |
Methods for identifying G protein coupled receptor effectors
|
US7235648B1
(en)
|
1993-03-31 |
2007-06-26 |
Cadus Technologies, Inc. |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US5876951A
(en)
*
|
1993-03-31 |
1999-03-02 |
Cadus Pharmaceutical Corporation |
Yeast cells engineered to produce pheromone system protein surrogates and uses therefor
|
US6100042A
(en)
*
|
1993-03-31 |
2000-08-08 |
Cadus Pharmaceutical Corporation |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US20030054402A1
(en)
*
|
1993-03-31 |
2003-03-20 |
Cadus Pharmaceutical Corporation |
Methods and compositions for identifying receptor effectors
|
US6864060B1
(en)
|
1993-03-31 |
2005-03-08 |
Cadus Technologies, Inc. |
Yeast cells expressing modified G proteins and methods of use therefor
|
US6150137A
(en)
*
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
US5989808A
(en)
*
|
1994-06-14 |
1999-11-23 |
American Cyanamid Company |
Identification of compounds affecting specific interaction of peptide binding pairs
|
US5695941A
(en)
*
|
1994-06-22 |
1997-12-09 |
The General Hospital Corporation |
Interaction trap systems for analysis of protein networks
|
US6576236B1
(en)
|
1994-07-01 |
2003-06-10 |
Dana Farber Cancer Institute |
Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain
|
EP1405911A1
(en)
|
1994-07-20 |
2004-04-07 |
The General Hospital Corporation |
Interaction trap systems for detecting protein interactions
|
US6399296B1
(en)
|
1994-07-20 |
2002-06-04 |
The General Hospital Corporation |
Interaction trap systems for detecting protein interactions
|
AU2983295A
(en)
*
|
1994-07-22 |
1996-02-22 |
Ciba-Geigy Ag |
Dual hybrid system
|
NZ306767A
(en)
*
|
1995-04-11 |
2000-03-27 |
Univ Johns Hopkins |
Method of identifying molecular interactions employing counterselection and at least two hybrid molecules or two hybrid systems
|
US5637463A
(en)
*
|
1995-05-04 |
1997-06-10 |
Hoffmann-La Roche Inc. |
Method to detect protein-protein interactions
|
US5821048B1
(en)
*
|
1995-06-07 |
2000-05-23 |
Harvard College |
Methods kits and compositions for diagnosing papillomavirus infection
|
US5968802A
(en)
*
|
1995-06-07 |
1999-10-19 |
Wang; Bruce |
Nuclear cyclophilin
|
US20030215798A1
(en)
*
|
1997-06-16 |
2003-11-20 |
Diversa Corporation |
High throughput fluorescence-based screening for novel enzymes
|
EP0790304A1
(en)
*
|
1995-12-21 |
1997-08-20 |
AMERSHAM INTERNATIONAL plc |
Improvements relating to assay systems
|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
WO1997044447A2
(en)
*
|
1996-05-03 |
1997-11-27 |
President And Fellows Of Harvard College |
Transcriptional activation system, activators, and uses therefor
|
US6083693A
(en)
*
|
1996-06-14 |
2000-07-04 |
Curagen Corporation |
Identification and comparison of protein-protein interactions that occur in populations
|
US5807708A
(en)
*
|
1996-07-30 |
1998-09-15 |
Millennium Pharmaceuticals, Inc. |
Conservin nucleic acid molecules and compositions
|
US5925523A
(en)
*
|
1996-08-23 |
1999-07-20 |
President & Fellows Of Harvard College |
Intraction trap assay, reagents and uses thereof
|
WO1998007845A1
(en)
*
|
1996-08-23 |
1998-02-26 |
President And Fellows Of Harvard College |
Interaction trap assay, reagents and uses thereof
|
JP2001501097A
(ja)
*
|
1996-09-24 |
2001-01-30 |
ケイダス ファーマスーティカル コーポレイション |
レセプターエフェクターを同定する方法及び組成物
|
US6048693A
(en)
*
|
1996-10-16 |
2000-04-11 |
Bittech, Inc. |
Phenotypic assays of cyclin/cyclin-dependent kinase function
|
AU4903897A
(en)
*
|
1996-10-16 |
1998-05-11 |
Bittech, Inc. |
Phenotypic assays of cyclin/cyclin-dependent kinase function
|
US20020137890A1
(en)
*
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
JP2001524824A
(ja)
|
1997-04-16 |
2001-12-04 |
ミレニアム・フアーマシユーチカルズ・インコーポレーテツド |
Crspタンパク質(システインに富む分泌性タンパク質)、それらをコードする核酸分子およびその用途
|
US6426411B1
(en)
|
1997-05-30 |
2002-07-30 |
Dana-Farber Cancer Institute |
PGC-1, a novel brown fat pparγ coactivator
|
US5885779A
(en)
*
|
1997-09-09 |
1999-03-23 |
University Of British Columbia |
Repressed trans-activator system for characterization of protein-protein interactions
|
US6344554B1
(en)
|
1997-10-02 |
2002-02-05 |
Regents Of The University Of California |
Polynucleotide sequences from Candida albicans encoding polypeptides associated with filamentous growth
|
US6332897B1
(en)
*
|
1998-03-27 |
2001-12-25 |
Glaxo Wellcome Inc. |
Assay methods
|
US6355473B1
(en)
|
1998-05-06 |
2002-03-12 |
Cadus Pharmaceutical Corp. |
Yeast cells having mutations in stp22 and uses therefor
|
US6733991B1
(en)
|
1998-05-08 |
2004-05-11 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses therefor
|
US6746852B1
(en)
|
1998-05-08 |
2004-06-08 |
Osi Pharmaceuticals, Inc. |
AGS proteins and nucleic acid molecules and uses thereof
|
CA2256121A1
(en)
*
|
1998-06-08 |
1999-12-08 |
Hong Wang |
Cyclin-dependent kinase inhibitors as plant growth regulators
|
US7273747B2
(en)
*
|
1998-08-27 |
2007-09-25 |
Cadus Technologies, Inc. |
Cell having amplified signal transduction pathway responses and uses therefor
|
US6251605B1
(en)
|
1998-10-27 |
2001-06-26 |
Cadus Pharmaceutical Corporation |
Yeast cells having mutations in Cav1 and uses therefor
|
WO2000031261A2
(en)
*
|
1998-11-25 |
2000-06-02 |
Cadus Pharmaceutical Corporation |
Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor
|
US6504008B1
(en)
|
1999-02-01 |
2003-01-07 |
Cadus Technologies, Inc. |
Cell based signal generation
|
EP2301947A3
(en)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Secreted proteins and uses thereof
|
WO2000053743A1
(en)
|
1999-03-12 |
2000-09-14 |
Gpc Biotech, Inc. |
Methods and reagents for identifying synthetic genetic elements
|
US7396905B1
(en)
|
1999-05-21 |
2008-07-08 |
Mckeon Frank |
Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
|
US6555325B1
(en)
*
|
1999-06-14 |
2003-04-29 |
Cadus Technologies, Inc. |
System for detection of a functional interaction between a compound and a cellular signal transduction component
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
MXPA02001877A
(es)
|
1999-08-23 |
2002-08-20 |
Dana Farber Cancer Inst Inc |
Pd-1, un receptor para b7-4, y usos del mismo.
|
US7223533B2
(en)
|
1999-09-10 |
2007-05-29 |
Cadus Technologies, Inc. |
Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways
|
US20020061512A1
(en)
*
|
2000-02-18 |
2002-05-23 |
Kim Jin-Soo |
Zinc finger domains and methods of identifying same
|
EP2143796A3
(en)
|
2000-02-29 |
2010-03-17 |
Millennium Pharmaceuticals, Inc. |
1983, 52881, 2398, 45449, 50289, and 52872, G protein-coupled receptors and uses therefor
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
AU2001263155A1
(en)
*
|
2000-05-16 |
2001-11-26 |
Massachusetts Institute Of Technology |
Methods and compositions for interaction trap assays
|
US7029847B2
(en)
*
|
2000-05-16 |
2006-04-18 |
Massachusetts Institute Of Technology |
Methods and compositions for interaction trap assays
|
AU6748901A
(en)
|
2000-05-30 |
2001-12-11 |
Bayer Aktiengesellschaft |
Regulation of human plc delta-1
|
US20030031675A1
(en)
|
2000-06-06 |
2003-02-13 |
Mikesell Glen E. |
B7-related nucleic acids and polypeptides useful for immunomodulation
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
EP1409638A4
(en)
|
2000-11-07 |
2004-05-19 |
Pioneer Hi Bred Int |
CELL CYCLE NUCLEIC ACIDS, POLYPEPTIDES AND THEIR USE
|
US20050191749A1
(en)
*
|
2000-12-08 |
2005-09-01 |
Bowdish Katherine S. |
Novel plasmid vectors
|
WO2002070678A2
(en)
|
2001-02-05 |
2002-09-12 |
Bayer Aktiengesellschaft |
Regulation of human serine/threonine protein kinase
|
WO2002074908A2
(en)
*
|
2001-03-02 |
2002-09-26 |
Mds Proteomics, Inc. |
Methods and reagents for regulating apoptosis
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
MXPA03008959A
(es)
|
2001-04-02 |
2004-10-15 |
Wyeth Corp |
Pd-1, un receptor para b7-4 y sus usos.
|
JP2005501518A
(ja)
|
2001-04-16 |
2005-01-20 |
ワイス・ホールディングズ・コーポレイション |
ポリペプチド抗原をコードしている新規ストレプトコッカスニューモニアエオープンリーディングフレームおよびその使用
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
NZ530094A
(en)
|
2001-05-31 |
2007-10-26 |
Performance Plants Inc |
Compositions and methods of increasing stress tolerance in plants transgenic for farnesyl transferase
|
EP2053406A3
(en)
*
|
2001-07-16 |
2009-06-24 |
caprotec bioanalytics GmbH |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
WO2003016571A1
(en)
*
|
2001-08-17 |
2003-02-27 |
Toolgen, Inc. |
Zinc finger domain libraries
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
AU2002352558A1
(en)
|
2001-11-09 |
2003-05-26 |
Dana-Farber Cancer Institute, Inc. |
Pgc-1beta, a novel pgc-1 homologue and uses therefor
|
AU2002361385B2
(en)
|
2001-12-18 |
2009-11-19 |
Centre National De La Recherche Scientifique Cnrs |
Novel death associated proteins of the THAP family and related Par4 pathways involved in apoptosis control
|
US7858297B2
(en)
|
2001-12-18 |
2010-12-28 |
Centre National De La Recherche Scientifique Cnrs |
Chemokine-binding protein and methods of use
|
AU2002359721A1
(en)
|
2001-12-19 |
2003-07-09 |
Bristol-Myers Squibb Company |
Pichia pastoris formate dehydrogenase and uses therefor
|
EP2436393A1
(en)
|
2001-12-19 |
2012-04-04 |
Millennium Pharmaceuticals, Inc. |
Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
|
JP2005532036A
(ja)
|
2002-01-09 |
2005-10-27 |
理化学研究所 |
癌プロフィール
|
US20020094519A1
(en)
*
|
2002-03-07 |
2002-07-18 |
Agencourt Bioscience Corporation |
Detection of protein interactions
|
DE60325847D1
(de)
*
|
2002-03-11 |
2009-03-05 |
Caprotec Bioanalytics Gmbh |
Verbindungen und verfahren für die analyse des proteoms
|
US20040116658A1
(en)
*
|
2002-03-22 |
2004-06-17 |
Ken-Shwo Dai |
Human KAP/Cdi1-related gene variant associated with small cell lung cancer
|
GB0207533D0
(en)
|
2002-04-02 |
2002-05-08 |
Oxford Glycosciences Uk Ltd |
Protein
|
EP1900827A3
(en)
|
2002-05-21 |
2008-04-16 |
Bayer HealthCare AG |
Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
|
AU2003247551C1
(en)
|
2002-06-17 |
2010-12-09 |
Thrasos Innovation, Inc. |
Single domain TDF-related compounds and analogs thereof
|
JP2006514823A
(ja)
|
2002-08-20 |
2006-05-18 |
ミレニアム ファーマスーティカルズ インク |
子宮頸癌の同定、評価、予防および治療を行うための組成物、キットおよび方法
|
WO2004047757A2
(en)
|
2002-11-21 |
2004-06-10 |
University Of Massachusets |
Diagnosing and treating hematopoietic cancers
|
EP2112229A3
(en)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
EP2474632B1
(en)
|
2002-12-20 |
2015-08-12 |
Celera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
CA2658334C
(en)
*
|
2003-01-16 |
2012-07-10 |
Caprotec Bioanalytics Gmbh |
Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
|
AU2004256425A1
(en)
|
2003-06-09 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
AU2004263896A1
(en)
|
2003-08-08 |
2005-02-17 |
Genenews Inc. |
Osteoarthritis biomarkers and uses thereof
|
EP1522594A3
(en)
|
2003-10-06 |
2005-06-22 |
Bayer HealthCare AG |
Methods and kits for investigating cancer
|
CN1964986A
(zh)
|
2003-10-07 |
2007-05-16 |
千年药品公司 |
用于鉴定、评价、预防和治疗卵巢癌的核酸分子和蛋白质
|
EP1711622A2
(en)
|
2003-11-26 |
2006-10-18 |
Applera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
JP5236286B2
(ja)
|
2004-05-07 |
2013-07-17 |
セレラ コーポレーション |
肝線維症に関連する遺伝的多型、その検出方法および使用
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
EP2789342A1
(en)
|
2004-06-17 |
2014-10-15 |
Thrasos Innovation, Inc. |
TDF-related compounds and analogs thereof
|
US7459529B2
(en)
|
2004-11-24 |
2008-12-02 |
Seoul National University Industry Foundation |
AIMP2-DX2 and its uses
|
US9944713B2
(en)
|
2004-11-24 |
2018-04-17 |
Medicinal Bioconvergence Research Center |
Antibody specific to the AIMP2-DX2
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
US8999944B2
(en)
|
2005-01-20 |
2015-04-07 |
University Of Rochester |
Thioredoxin interacting protein (TXNIP) as regulator of vascular function
|
JP5265923B2
(ja)
|
2005-02-07 |
2013-08-14 |
ジーンニュース インコーポレーテッド |
軽度の変形性関節症のバイオマーカーおよびその使用
|
EP1695981A1
(de)
|
2005-02-25 |
2006-08-30 |
Forschungsverbund Berlin e.V. |
Verfahren zum Redox-Potential-abhängigen Nachweis von Targetmolekülen durch wechselwirkende Polypeptide
|
EP2113572B1
(en)
|
2005-03-11 |
2012-12-05 |
Celera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
EP2491926B1
(en)
|
2005-03-22 |
2018-05-09 |
President and Fellows of Harvard College |
Treatment of protein degradation disorders
|
JP2008536869A
(ja)
|
2005-04-15 |
2008-09-11 |
プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ |
Krc活性を調節することによる骨形成および石灰化の調節方法
|
CA2612021A1
(en)
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US9957569B2
(en)
|
2005-09-12 |
2018-05-01 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
AU2006291054B2
(en)
|
2005-09-12 |
2011-10-13 |
The Brigham And Women's Hospital, Inc. |
Recurrent gene fusions in prostate cancer
|
ES2537527T3
(es)
|
2005-09-20 |
2015-06-09 |
Thrasos Innovation, Inc. |
Compuestos relacionados con el TDF y análogos de los mismos
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US8652467B2
(en)
|
2005-10-14 |
2014-02-18 |
The Regents Of The University Of Michigan |
Dek protein compositions and methods of using the same
|
WO2007048074A1
(en)
|
2005-10-21 |
2007-04-26 |
Genenews Inc. |
Method and apparatus for correlating levels of biomarker products with disease
|
CA2628116A1
(en)
|
2005-10-31 |
2007-12-13 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
EP2368912B1
(en)
|
2006-01-05 |
2017-05-03 |
Children's Medical Center Corporation |
Regulators of NFAT
|
AR059448A1
(es)
|
2006-02-13 |
2008-04-09 |
Divergence Inc |
Polipeptidos quimericos vegetales de union para el reconocimiento molecular universal
|
WO2008091349A1
(en)
|
2006-02-14 |
2008-07-31 |
The President And Fellows Of Harvard College |
Bifunctional histone deacetylase inhibitors
|
CA2654540C
(en)
|
2006-05-03 |
2017-01-17 |
President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
AU2007257162A1
(en)
|
2006-06-05 |
2007-12-13 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
WO2008051511A2
(en)
|
2006-10-20 |
2008-05-02 |
Applera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
WO2008104803A2
(en)
|
2007-02-26 |
2008-09-04 |
Oxford Genome Sciences (Uk) Limited |
Proteins
|
EP3118221B1
(en)
|
2007-02-26 |
2019-08-21 |
Oxford BioTherapeutics Ltd |
Proteins
|
EP2243834A1
(en)
|
2007-03-05 |
2010-10-27 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
EP2581081A3
(en)
|
2007-06-01 |
2013-07-31 |
The Trustees Of Princeton University |
Treatment of viral infections by modulation of host cell metabolic pathways
|
US8158757B2
(en)
|
2007-07-02 |
2012-04-17 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for treating and diagnosing cancer
|
ES2376509T3
(es)
|
2007-07-06 |
2012-03-14 |
The Regents Of The University Of Michigan |
Reordenamientos de genes mipol 1-etv1.
|
CA2692441C
(en)
|
2007-07-06 |
2020-01-21 |
The Regents Of The University Of Michigan |
Solute carrier family 45 member 3 (slc45a3) and ets family gene fusions in prostate cancer
|
WO2009038770A2
(en)
|
2007-09-20 |
2009-03-26 |
University Of Massachusetts Cvip |
Detoxified recombinant botulinum neurotoxin
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
EP2227556B1
(en)
|
2007-11-19 |
2014-08-27 |
Celera Corporation |
Lung cancer markers and uses thereof
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
EP2878680B1
(en)
|
2008-07-09 |
2016-06-08 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
|
WO2010011296A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Deacetylase inhibitors and uses thereof
|
EP2328908A4
(en)
|
2008-08-28 |
2012-11-28 |
Univ New York State Res Found |
TREATMENT OF AMYLOIDOSES BASED ON MYELIN BASED PROTEIN AND FRAGMENTS THEREOF
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
WO2010037041A2
(en)
|
2008-09-26 |
2010-04-01 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
US9207242B2
(en)
|
2008-10-09 |
2015-12-08 |
The University Of Hong Kong |
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
|
CN102272599B
(zh)
|
2008-11-11 |
2015-01-14 |
密执安大学评议会 |
抗cxcr1组合物和方法
|
US9181315B2
(en)
|
2009-01-08 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for induced brown fat differentiation
|
JP2012514475A
(ja)
|
2009-01-09 |
2012-06-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
癌における再現性の遺伝子融合物
|
WO2010084408A2
(en)
|
2009-01-21 |
2010-07-29 |
Oxford Biotherapeutics Ltd. |
Pta089 protein
|
US20120121706A1
(en)
|
2009-04-10 |
2012-05-17 |
Tufts Medical Center, Inc. |
PAR-1 Activation by Metalloproteinase-1 (MMP-1)
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
US9938582B2
(en)
|
2009-09-17 |
2018-04-10 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
US20120282177A1
(en)
|
2009-11-02 |
2012-11-08 |
Christian Rohlff |
ROR1 as Therapeutic and Diagnostic Target
|
CA2778953C
(en)
|
2009-11-13 |
2020-01-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
|
US20130183326A9
(en)
|
2009-11-20 |
2013-07-18 |
St. Jude Children's Research Hospital |
Methods and compositions for modulating the activity of the interleukin-35 receptor complex
|
ES2577017T3
(es)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedimientos y kits para identificar la aneuploidia
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
AU2011207210A1
(en)
|
2010-01-22 |
2012-08-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders
|
WO2011116209A2
(en)
|
2010-03-17 |
2011-09-22 |
The Regents Of The University Of Michigan |
Using phage epitopes to profile the immune response
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
CN107098958B
(zh)
|
2010-03-26 |
2021-11-05 |
达特茅斯大学理事会 |
Vista调节性t细胞介体蛋白、vista结合剂及其用途
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
CA2794674A1
(en)
|
2010-04-01 |
2011-10-06 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
GB201012420D0
(en)
|
2010-07-23 |
2010-09-08 |
Univ Erasmus Medical Ct |
Foetal heamoglobin inhibitor
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
US8945556B2
(en)
|
2010-11-19 |
2015-02-03 |
The Regents Of The University Of Michigan |
RAF gene fusions
|
US9956236B2
(en)
|
2011-02-07 |
2018-05-01 |
Cornell University |
Methods for increasing immune responses using agents that directly bind to and activate IRE-1
|
US20140157443A1
(en)
|
2011-04-14 |
2014-06-05 |
St. Jude Children's Research Hospital |
Methods and compositions for detecting and modulating a novel mtor complex
|
KR102046666B1
(ko)
|
2011-05-25 |
2019-11-19 |
이나뜨 파르마 |
염증성 장애의 치료를 위한 항-kir 항체
|
PL2726094T3
(pl)
|
2011-06-28 |
2017-06-30 |
Oxford Biotherapeutics Ltd |
Cel terapeutyczny i diagnostyczny
|
US10093705B2
(en)
|
2011-09-13 |
2018-10-09 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for brown fat induction and activity using FNDC5
|
US9127040B2
(en)
|
2011-09-20 |
2015-09-08 |
The University Of North Carolina At Chapel Hill |
Regulation of sodium channels by PLUNC proteins
|
LT2814844T
(lt)
|
2012-02-15 |
2017-10-25 |
Novo Nordisk A/S |
Antikūnai, kurie jungiasi ir blokuoja ekspresuotą ant mieloidinių ląstelių inicijuojantį receptorių 1 (trem-1)
|
RS57827B1
(sr)
|
2012-02-15 |
2018-12-31 |
Novo Nordisk As |
Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
EP4155401A1
(en)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US9408832B2
(en)
|
2012-03-14 |
2016-08-09 |
University Of Central Florida Research Foundation, Inc. |
LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9730941B2
(en)
|
2012-06-07 |
2017-08-15 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the inhibition of Pin1
|
EP2864352B1
(en)
|
2012-06-22 |
2018-08-08 |
The Trustees Of Dartmouth College |
Novel vista-ig constructs and the use of vista-ig for treatment of autoimmune, allergic and inflammatory disorders
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
GB201213652D0
(en)
|
2012-08-01 |
2012-09-12 |
Oxford Biotherapeutics Ltd |
Therapeutic and diagnostic target
|
CA2884704C
(en)
|
2012-09-07 |
2023-04-04 |
Randolph J. Noelle |
Vista modulators for diagnosis and treatment of cancer
|
EP2909341A2
(en)
|
2012-10-18 |
2015-08-26 |
Oslo Universitetssykehus HF |
Biomarkers for cervical cancer
|
WO2014066328A1
(en)
|
2012-10-23 |
2014-05-01 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
JP2016510411A
(ja)
|
2013-02-04 |
2016-04-07 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Wnt経路インヒビターによる処置の方法およびモニタリング
|
GB201302447D0
(en)
|
2013-02-12 |
2013-03-27 |
Oxford Biotherapeutics Ltd |
Therapeutic and diagnostic target
|
EP2971100A1
(en)
|
2013-03-13 |
2016-01-20 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
EP3293275B1
(en)
|
2013-06-06 |
2021-08-04 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment prevention, and treatment of cancer using pd-l1 isoforms
|
EP3027225B1
(en)
|
2013-07-31 |
2021-03-24 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating thermogenesis using transforming growth factor alpha
|
US9957506B2
(en)
|
2013-09-25 |
2018-05-01 |
Cornell University |
Compounds for inducing anti-tumor immunity and methods thereof
|
MX369173B
(es)
|
2013-12-24 |
2019-10-30 |
Janssen Pharmaceutica Nv |
Anticuerpos y fragmentos anti-vista.
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
US11365447B2
(en)
|
2014-03-13 |
2022-06-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
CN107073109B
(zh)
|
2014-06-11 |
2021-08-06 |
凯西·A·格林 |
Vista激动剂和拮抗剂抑制或增强体液免疫的用途
|
MX2017000484A
(es)
|
2014-07-17 |
2017-05-01 |
Novo Nordisk As |
Mutagenesis dirigida al sitio anticuerpos receptor desencadenante expresado en las celulas mieloides de tipo 1 (trem-1) para reducir la viscosidad.
|
WO2016011265A2
(en)
|
2014-07-17 |
2016-01-21 |
Beth Israel Deaconess Medical Center, Inc. |
Biomarkers for pin1-associated disorders
|
US9968579B2
(en)
|
2014-07-17 |
2018-05-15 |
Beth Isreal Deaconess Medical Center, Inc. |
ATRA for modulating Pin1 activity and stability
|
WO2016090347A1
(en)
|
2014-12-05 |
2016-06-09 |
Immunext, Inc. |
Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators
|
EP3268025B1
(en)
|
2015-03-10 |
2020-05-06 |
University of Massachusetts |
Targeting gdf6 and bmp signaling for anti-melanoma therapy
|
US10548864B2
(en)
|
2015-03-12 |
2020-02-04 |
Beth Israel Deaconess Medical Center, Inc. |
Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
|
BR112017027870A2
(pt)
|
2015-06-24 |
2018-08-28 |
Janssen Pharmaceutica Nv |
anticorpos e fragmentos anti-vista
|
AU2016343978A1
(en)
|
2015-10-29 |
2018-05-17 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using PM20D1 and N-lipidated amino acids
|
BR112018016461A2
(pt)
|
2016-02-12 |
2019-10-01 |
Janssen Pharmaceutica Nv |
anticorpos e fragmentos anti-vista, usos dos mesmos e métodos de identificação dos mesmos
|
WO2017162659A1
(en)
|
2016-03-24 |
2017-09-28 |
Bayer Pharma Aktiengesellschaft |
Intracellular hepsin as therapeutic target for the treatment of cancer with centrosome amplification
|
MX2018012469A
(es)
|
2016-04-15 |
2019-07-04 |
Immunext Inc |
Anticuerpos vista antihumanos y uso de los mismos.
|
EA202092302A1
(ru)
|
2018-04-02 |
2021-02-02 |
Бристол-Майерс Сквибб Компани |
Антитела к trem-1 и их применения
|
US12006550B2
(en)
|
2020-10-12 |
2024-06-11 |
University Of South Carolina |
Targeting treatment for ADAM30 in pathological cells
|